University of Minnesota invention will help speed development of drug treatments for heart failure
Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure. Chronic heart failure is an increasingly important health problem. It is the leading medical cause of hospitalization and is expected to result in an estimated direct and indirect cost to the health care system of $37.2 billion in 2009 alone. About 5.7 million people in the United States have heart failure, and it contributes to or causes some 290,000 deaths annually. However, developing new treatments is an extremely costly and time-consuming process, taking nearly a decade to gain regulatory approval and requiring hundreds of millions of dollars.
The technology, developed by the universitys David Thomas and Razvan Cornea and Celladon Corporations Krisztina Zsebo, allows for increased screening efficiency of compounds capable of disrupting the interactions of proteins implicated in the development of heart failure. Fluorescence resonance energy transfer (FRET) is used to measure disruption of the calcium regulatory system, which has long been implicated in cardiovascular disease. This will provide key information on a particular drugs likelihood of success early in the screening process, since compounds that decrease FRET are good candidates for further development.
"Dr. Cornea and I, along with our students, have worked for more than a decade developing methods for preparing membranes from purified components, and using FRET to detect changes in protein interactions," Thomas said. "Scientists from Celladon saw the potential for drug discovery, and this resulted in a breakthrough that has added an exciting new dimension to our research program."
The high-throughput assay, developed by the university team, is based on a reconstituted membrane system composed of purified lipid and protein components. This technique is especially important because the interactions of integral membrane proteins are more complex than soluble proteins, making it very difficult to produce a synthetic system that recapitulates the cellular interactions in a large-scale and reproducible manner.
Celladon, based in La Jolla, Calif., has acquired an exclusive license for the technology from the University of Minnesota for the development of molecular therapies for cardiovascular diseases. Celladon also provided funding for the research that allowed Thomas to further refine the assay.
"This technology is very important to the efficient selection and advancement of compounds with the potential to increase cardiac contractility and potentially accelerates product opportunities that will ultimately benefit patients and development partners alike," said Krisztina M. Zsebo, Ph.D., president and chief executive officer of Celladon Corporation. "Celladon's investigation and development of first-in-class CDN small molecules as intravenous and oral drugs for the treatment of acute and chronic heart failure sets us apart in the cardiovascular field and presents multiple partnering opportunities."
Source: University of Minnesota
- University of Minnesota engineers invent new device that could increase Internet download speeds Tue, 2 Oct 2012, 22:02:39 EDT
- New strategies to improve treatment and avert heart failure in childrenFri, 23 Apr 2010, 11:55:38 EDT
- The drug treatment of heart failure is influenced by the gender of the patient and of the physicianThu, 22 Jan 2009, 10:59:52 EST
- Heart Failure Congress 2009Mon, 6 Apr 2009, 11:36:23 EDT
- Recommended treatment for heart failure often underusedTue, 20 Oct 2009, 16:32:05 EDT
- Invention will help speed development of drug treatments for heart failurefrom Science DailyThu, 26 Nov 2009, 20:14:13 EST
- Technology can spur heart failure therapyfrom UPIWed, 25 Nov 2009, 9:21:15 EST
- University of Minnesota invention will help speed development of drug treatments for heart failurefrom Science CentricTue, 24 Nov 2009, 9:14:12 EST
- Invention will help speed development of drug treatments for heart failurefrom PhysorgMon, 23 Nov 2009, 16:28:14 EST
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Allosaurus fed more like a falcon than a crocodile, new study finds
- Invasive crazy ants are displacing fire ants in areas throughout southeastern US
- Beautiful 'flowers' self-assemble in a beaker
- Scientific insurgents say 'Journal Impact Factors' distort science
- GPS solution provides 3-minute tsunami alerts